MAXImune 400 Tablet contains Pidotimod 400 mg, an immunostimulant agent used to enhance the body's immune response. Pidotimod acts by modulating both innate and adaptive immunity, promoting the activation and proliferation of T-lymphocytes and increasing the production of cytokines, thereby improving host defense mechanisms against infections. MAXImune 400 is indicated as an adjunctive therapy in the prevention and treatment of recurrent respiratory tract infections, including bronchitis, sinusitis, and pharyngitis, particularly in patients with compromised or weakened immune systems. The tablet is administered orally, with dosage and duration tailored according to the clinical condition and physician’s recommendation. Commonly, it is prescribed for pediatric and adult patients to reduce the frequency and severity of infections. MAXImune 400 is generally well tolerated; however, hypersensitivity reactions may occur in rare cases. It should be used cautiously in patients with autoimmune disorders or hypersensitivity to any component of the formulation. Concomitant use with other immunomodulatory agents requires medical supervision. Regular monitoring and adherence to prescribed dosage are essential to achieve optimal therapeutic outcomes. MAXImune 400 Tablet is a valuable option in immunoprophylaxis and immune support therapy.